Historical record - last NADAC publication: 2/17/2021
Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1295 per EA under NDC 69097081107. Its NADAC has been published 233 times since Sep 14, 2016.
Strength
800 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081107
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/17/2021
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA202764On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 233 times since Sep 14, 2016, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1295 per EA |
|---|---|
| All-time high | $0.1892 (Mar 15, 2017) |
| All-time low | $0.1170 (Sep 23, 2020) |
| Median price | $0.1310 |
| Average price | $0.1354 |
| Largest weekly change | +16.6% (May 23, 2018) |
| Weeks tracked | 233 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Cipla USA Inc., is $0.1295 per EA (NDC 69097081107), effective Feb 24, 2021.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 30.3%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Sep 14, 2016, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.1170 (Sep 23, 2020) to a high of $0.1892 (Mar 15, 2017), with a median of $0.1310 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
Yes. 21 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 800 MG TABLET, is $0.0963 per EA — about 26% below GABAPENTIN 800 MG TABLET.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 69097081107) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification